The field of device based therapy in heart failure continues to develop at a fast pace. Advancements in ventricle restoration strategies, device based strategies to improve cardiac output and new monitoring systems only represent a small proportion of the potential for cutting edge technologies and emerging platforms in this new field.
The 3rd D-HF congress will take place in Berlin, December 15 – 16, 2017. Innovation is at the forefront of this meeting and our faculty of leading experts and pioneers in the field will provide a comprehensive update on the latest research, trials and clinical practice. The program will include lectures, debates and recorded / live cases and opportunities for questions and discussion will be provided throughout the meeting.
On the afternoon of December 16, we are planning a workshop exclusively for industry representatives, which will cover European and US rules and regulations of device development with a particular focus on how to design clinical trials. The aim of this meeting is to encourage direct dialogue between those that are writing the regulations and those that are creating devices and develop the clinical trials to test them.
We look forward to seeing you in Berlin.
Horst Sievert, Navin Kapur, Sameer Gafoor, Stefan Anker, William Abraham
This meeting will be supported by the CSI Foundation, a not-for-profit organization formed to aid the development of structural,
congenital and valvar heart interventions worldwide. CSI Foundation members will receive discounted entry to this event. For more information, please visit the CSI Foundation webpage
Board of Directors
Horst Sievert, MD
CardioVascular Center Frankfurt CVC
Navin Kapur, MD
Tufts Medical Center
Sameer Gafoor, MD
Swedish Heart and Vascular Institue
Stefan Anker, MD
University Medical Center
William T. Abraham, MD
Ohio State University Wexner Medical Center
Columbus, OH, USA